Phase 4 Breast Cancer Trial, Recruiting NCT05206331 Sponsor: Margarita Louise Zuley Condition: Breast Cancer
Back to Breast Cancer

Phase 4 Breast Cancer Trial, Recruiting

NCT05206331
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female, of any race or ethnicity
  • People who are 30 years of age or older
  • People who have been found to have a suspicious area in their breast and are already scheduled for an imaging-guided breast biopsy

Who may not be able to join:

  • People who are unable or unwilling to give their informed consent to take part
  • People who have a breast implant in the breast being studied
  • People who are currently pregnant
  • People who are currently breastfeeding
  • People who are actively receiving chemotherapy for any type of cancer
  • People whose kidneys are not functioning well enough (specifically, those with an eGFR score below 30 — confirm with trial site if unsure what this means for a specific situation)
  • People who have previously had a reaction to iodinated contrast dye, or who have a known allergy to it

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Margarita L Zuley, MD, University of Pittsburgh

Phone: 412-647-7385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Margarita Louise Zuley
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Negative Predictive Value (NPV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov